1. CHAHIRA MAZOUZI - Medical Oncology Department, University Hospital Center/University of BEJAIA.
2. RADIA BENYAHIA - Radiology Department, Pierre Marie Curie Center Algiers.
3. ESMA KERBOUA - Medical Oncology Department, Pierre Marie Curie Center Algiers.
4. MOUSSA MESSALI - Health Economics Department, University of Bejaïa.
5. GHOZLANE KACHER - Gastroenterology Service Private Center “Rameaux Des Oliviers“.
The economic evaluation finds its justification in the impossible market regulation of the health sector. Most sectors of the economy are in fact governed by market mechanisms which encourage consumers and producers to make the best use of the limited resources available to society, according to their own
interests. The health sector escapes this mode of operation, in particular because of the difficulty for the consumer to access all the information allowing them to judge the characteristics (quality and price) of the health good or service which would be beneficial to them. We were called upon to carry out a mass screening strategy for colorectal cancer in the wilaya of Bejaia, this screening concerned more than 3000 citizens, the crucial and decisive step for maintaining this screening was to evaluate the cost-effectiveness of this operation which aims primarily to reduce mortality and the incidence of this cancer which remains a public health problem in Algeria. The main objective of this article is to have all the cost data linked to screening or management of CRC only in order to be able to estimate the different cost items linked to the disease and to ensure the medico-economic evaluation. organized screening carried out between 2017 and 2020 as part of the Algerian cancer plan in the wilaya of Bejaia. Screening for CRC with an immunological test cost more than 12 million dinars. Direct medical costs represent more than two thirds of the cost, or a rate of 69.6%. This study evaluated the cost-effectiveness ratio for a single screening strategy in the general population (50-74 years) based on the FIT. Direct and indirect costs were estimated from different sources. However, the problem deserves to be mentioned and taken up again in a few years. Such economic quantification is difficult, in particular because of the great complexity of estimating the cost of cancer in Algeria, including colorectal cancer, but also because of the absence of an epidemiological benchmark, notably data on mortality from cancer. colorectal cancer
MEDICAL-ECONOMIC APPROACH TO MASS SCREENING FOR COLORECTAL CANCER IN THE WILAYA OF BEJAÏA